Selected article for: "acute respiratory syndrome and SARS severe acute respiratory syndrome"
Author: Lipkin, W. Ian
Title: Biocontainment in Gain-of-Function Infectious Disease Research
  • Document date: 2012_10_9
    • ID: 6ma0r3xp_3
    Snippet: Other authors featured in this issue address the risk-to-benefit ratio of conducting H5N1 gain-of-function research. For the purposes of this discussion, I will assume the work is going forward and focus my arguments on where the research should be conducted. My views reflect on-the-ground experience with the severe acute respiratory syndrome (SARS) pandemic of 2003, 10 years as director of the Northeast Biodefense Center (the largest National In.....
    Document: Other authors featured in this issue address the risk-to-benefit ratio of conducting H5N1 gain-of-function research. For the purposes of this discussion, I will assume the work is going forward and focus my arguments on where the research should be conducted. My views reflect on-the-ground experience with the severe acute respiratory syndrome (SARS) pandemic of 2003, 10 years as director of the Northeast Biodefense Center (the largest National Institutes of Health Regional Center of Excellence for Biodefense and Emerging Diseases), director of the World Health Organization Collaborating Centre for Diagnostics in Zoonotic and Emerging Infectious Diseases, and cochair of the National Biosurveillance Advisory Subcommittee. They are, nonetheless, my views rather than those of the people and organizations I serve.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and benefit risk ratio: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory syndrome and discussion purpose: 1, 2
    • acute respiratory syndrome and forward go: 1, 2
    • acute respiratory syndrome and function gain: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory syndrome and function gain research: 1, 2, 3, 4
    • acute respiratory syndrome and infectious disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and issue feature: 1
    • acute respiratory syndrome and organization people: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory syndrome and research conduct: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory syndrome and respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • benefit risk and discussion purpose: 1
    • benefit risk and forward go: 1, 2
    • benefit risk and function gain: 1, 2, 3, 4
    • benefit risk and function gain research: 1, 2, 3
    • benefit risk and infectious disease: 1, 2, 3, 4, 5, 6
    • benefit risk and research conduct: 1, 2
    • benefit risk and respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • benefit risk ratio and function gain: 1
    • benefit risk ratio and infectious disease: 1